Trial Profile
Skeletal Physiology Dysregulation in Obesity: The Role of Growth Hormone
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Metabolic bone diseases; Somatotropin deficiency
- Focus Therapeutic Use
- 05 Jul 2019 Status changed from active, no longer recruiting to completed.
- 21 Jan 2019 Planned End Date changed from 1 Apr 2019 to 30 Apr 2019.
- 08 May 2017 Planned End Date changed from 1 Apr 2018 to 1 Apr 2019.